Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Biopharmaceutical Excipients Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The biopharmaceutical excipients market size has experienced robust growth in recent years. This market is projected to expand from $3.27 billion in 2025 to $3.57 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.2%. Historically, this growth can be attributed to several factors including increasing biologic drug approvals, the early adoption of protein stabilizers, a rise in injectable formulations, the expansion of vaccine development, and advancements in formulation science.
The biopharmaceutical excipients market size is anticipated to experience robust expansion over the next few years. This market is projected to reach $5.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period can be attributed to factors such as the increasing complexity of biologic formulations, a rising demand for products with extended shelf lives, the expansion of cell and gene therapies, a heightened regulatory focus on excipient safety, and increased investments in advanced drug delivery systems. Major trends expected in this period include a growing demand for high-purity biologic excipients, an increasing use of multifunctional formulation ingredients, the broadening application of excipients for cell and gene therapies, a rising emphasis on stability-enhancing compounds, and more tailored customization of excipient solutions.
Get A Free Sample Report With In-Depth Market Insights:
Biopharmaceutical Excipients Market Demand Drivers: What’s Powering Industry Growth?
The expanding need for vaccine creation is projected to fuel the advancement of the biopharmaceutical excipients market moving ahead. Vaccine creation involves the method of designing and producing immunizations to combat infectious illnesses and enhance public well-being, necessitating premium excipients for the stability, effectiveness, and security of these vaccine products. This rising demand for vaccine development originates from a worldwide emphasis on avoiding infectious ailments, bolstering public health readiness, and expediting research to provide quicker and more potent immunization options. Biopharmaceutical excipients are crucial in vaccine formulations, as they stabilize antigens, boost solubility, and preserve integrity throughout storage and distribution. An illustration of this trend is seen in 2025, when the Centers for Disease Control and Prevention, a US-based national public health agency, reported an increase in adolescent vaccination coverage for critical vaccines like tetanus, diphtheria, and acellular pertussis from 89.9% in 2022 to 91.3% in 2024. During the identical timeframe, meningococcal conjugate vaccine coverage climbed from 88.6% to 90.1%, and human papillomavirus vaccine coverage (=2 doses) saw a substantial rise from 76.0% to 92.6%. Consequently, the expanding need for vaccine development is propelling the expansion of the biopharmaceutical excipients market.
Biopharmaceutical Excipients Market Segment Landscape: Which Areas Lead Development?
The biopharmaceutical excipients market covered in this report is segmented –
1) By Product Types: Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents
2) By Type Of Biologics: Antibodies, Vaccines, Cell Therapies, Other Biologics
3) By Functionality: Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives
4) By Application: Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy
5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes
Subsegments:
1) By Binders: Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders
2) By Coatings: Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings
3) By Diluents: Lactose, Microcrystalline Cellulose, Starch, Mannitol
4) By Disintegrants: Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate
5) By Lubricants And Glidants: Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide
6) By Polyols: Sorbitol, Mannitol, Glycerol, Xylitol
7) By Preservatives: Parabens, Benzoates, Sorbates, Phenols
8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate
9) By Suspending And Viscosity Agents: Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers
Biopharmaceutical Excipients Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading companies within the biopharmaceutical excipients market are emphasizing technological advancements, including ultra-high purity surfactants, aimed at improving protein stability, preventing degradation, and ensuring regulatory compliance for injectable formulations. These ultra-high purity surfactants consist of precisely refined surface-active agents that possess minimal impurities and a consistent composition, specifically formulated to guarantee stability, safety, and optimal performance in delicate pharmaceutical and biopharmaceutical preparations. An example of this trend occurred in September 2025, when Evonik Industries AG, a Germany-based chemicals company, unveiled MaxiPure Polysorbate 80, intended for injectable and biopharmaceutical applications. This particular excipient has been developed to feature an oleic acid content surpassing ninety-eight percent, remarkable clarity, and complete adherence to European Pharmacopoeia, United States Pharmacopoeia, Japanese Pharmacopoeia, and Chinese Pharmacopoeia standards. It effectively tackles significant issues regarding protein stability, inhibits oxidative degradation, facilitates reliable solubilization of hydrophobic active pharmaceutical ingredients, and boosts overall formulation reliability. Through the incorporation of this excipient, Evonik supports pharmaceutical and biopharmaceutical companies in the efficient development of complex biologics and injectable therapies, simultaneously ensuring both safety and compliance.
Biopharmaceutical Excipients Market Industry Leaders And Competitive Landscape
Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Frères, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Söhne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.
View The Full Biopharmaceutical Excipients Market Report:
Biopharmaceutical Excipients Market Geographic Spread And Regional Opportunities
North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model